• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular mechanisms of intrahepatic metastasis of hepatocellular carcinoma and application for diagnosis and treatment

Research Project

Project/Area Number 12470049
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Human pathology
Research InstitutionNATIONAL CANCER CENTER

Principal Investigator

SAKAMOTO Michiie  National Cancer Center Research Institure, Pathology Division, Chief, 研究所・病理部, 部長 (40221270)

Co-Investigator(Kenkyū-buntansha) FUJII Gen  National Cancer Center Research Institure, Pathology Division, Researcher, 研究所・病理部, 研究員 (90321877)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥5,700,000 (Direct Cost: ¥5,700,000)
Fiscal Year 2001: ¥2,300,000 (Direct Cost: ¥2,300,000)
Fiscal Year 2000: ¥3,400,000 (Direct Cost: ¥3,400,000)
Keywordshepatocellular carcinoma / invasion and metastasis / cell motility / integrin / c-Src / Rho kinase / gene expression analysis / CO-029 / DRH1 / VDUP1 / tetraspanin / 転移 / カドヘリン / Rho
Research Abstract

Intrahepatic metastasis is one of the most important prognostic factors for patients with hepatocellular carcinoma (HCC). Cell motility mediated by Rho-and p160 Rho-associated coiled-coil forming protein kinase (p160ROCK) signaling pathways has recently been shown to play a critical role in intrahepatic metastasis in human HCC. One of such highly metastatic cell line, KYN-2 cells having a high level of c-Src kinase activity become scattered, extend lamellipodia, and exhibit high motility in adherent condition. Expression of a dominant-negative mutant form of c-Src caused formation of stress fibers and focal adhesions, and markedly reduced motility. it was suggested that c-Src activation is critically involved in carcinoma cell migration and metastasis. To investigate whether the specific p160ROCK inhibitor Y-27632 could also inhibit intrahepatic metastasis, the effect of Y-27632 on the cell motility and intrahepatic metastasis of Li7 was investigated. Y-27632 markedly blocked actin reo … More rganization and motility of Li7 cells mediated by lysophosphatidic acid. Y-27632 was administered continuously into the peritoneal cavity using a micro-osmotic pump, together with orthotopic implantation of Li7 cells into the liver of SCID mice. The incidence of mice with metastatic nodules decreased in the Y-27632-treated group. These findings confirm the importance of the Rho/p160ROCK signaling pathway in intrahepatic metastasis of human HCC, and indicate that Y-27632 may be useful for the prevention of intrahepatic metastasis of human HCC.
Crucial genes involved in liver cancer metastasis were screened using differential display analysis. A novel gene, DRH1, which is frequently down-regulated in HCC was identified. CO-029 was found to be frequently and significantly overexpressed in HCC and in tumors with intrahepatic spreading. In contrast, mRNA expression of the other tetraspanins CD9 and CD82 was down-regulated in HCC, especially in tumors with intrahepatic spreading. It was suggested that CO-029 has some roles in the promotion of metastasis of HCC. Less

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (20 results)

All Other

All Publications (20 results)

  • [Publications] Genda T., Sakamoto M., et al.: "Loss of cell-cell contact is induced by integrin-mediated cell-substratum adhesion in highly-motile and highly-metastatic hepatocellular carcinoma cells"Lab. Invest.. 80(3). 387-394 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Takamura M., Sakamoto M., et al.: "Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632"Hepatology. 33(3). 577-581 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yamamoto Y., Sakamoto M., et al.: "Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma"Clin. Cancer Res.. 7(2). 297-303 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sakamoto M., et al.: "Involvement of c-Src in carcinoma cell motility and metastasis"Jpn. J. Cancer Res.. 92(9). 941-946 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Kanetaka K., Sakamoto M., et al.: "Overexpression of tetraspanin CO-029 in hepatocellular carcinoma"J. Hepatology. 35. 637-642 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Gotoh M., Sakamoto M., et al.: "Overexpression of osteopontin in hepatocellular carcinoma"Pathol. Int.. 52(1). 19-24 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Takuya Genda, Michiie Sakamoto, Takafumi Ichida, Hitoshi Asakura, Setsuo Hirohashi: "Loss of cell-cell contact is induced by integrin-mediated cell-substratum adhesion in highly-motile and highly-metastatic hepatocellular carcinoma cells"Lab. Invest.. 80(3). 387-394 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masaaki Takamura, Michiie Sakamoto, Takuya Genda, Takafumi Ichida, Hiroshi Asakura, Setsuo Hirohashi: "Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632"Hepatology. 33(3). 577-581 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yoshiya Yamamoto, Michiie Sakamoto, Gen Fujii, Kengo Kanetaka, Masahiro Asaka, Setsuo Hirohashi: "Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma"Clin. Cancer Res.. 7(2). 297-303 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Michiie Sakamoto, Masaaki Takamura, Yoshinori Ino, Ayaka Miura, Takuya Genda, Setsuo Hirohashi: "Involvement of c-Src in carcinoma cell motility and metastasis"Jpn. J. Cancer Res.. 92(2). 941-946 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Kengo Kanetaka, Michiie Sakamoto, Yoshiya Yamamoto, Susumu Yamasaki, Francois Lanza, Takashi Kanematsu, Setsuo Hirohashi: "Overexpression of tetraspanin CO-029 in hepatocellular carcinoma"J. Hepatol.. 35. 637-642 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masahiro Gotoh, Michiie Sakamoto, Kengo Kanetaka, Makoto Chuuma, Setsuo Hirohashi: "Overexpression of osteopontin in hepatocellular carcinoma"Path. Int.. 52(1). 19-24 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Takamura M., Sakamoto M., et al.: "Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protc4n kinase inhibitor Y-27632."Hepatology. 33(3). 577-581 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yamamoto Y., Sakamoto., et al.: "Cloning and characterization of a novel gene, DRHJ, down-regulated in advanced human hepatocellular carcinoma."Clin. Cancer Res.. 7(2). 297-303 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Kanetaka K., Sakamoto M., et al.: "Involvement of c-Src in carcinoma cell motility and metastasis."Jpn. J. Cancer Res.. 92(9). 941-946 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Kanetaka K., Sakamoto M., et al.: "Overexpression of tetraspanin CO-029 in hepatocellular carcinoma."J. Hepatology. 35. 637-642 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Gotoh M., Sakamoto M., et al.: "Overexpression of osteopontin in hepatocellular carcinoma."Pathol. Int.. 52(1). 19-24 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Genda,T.,Sakamoto,M.,Ichida,M.,Asakura,H.,Hirohashi,S.: "Loss of cell-cell contact is induced by integrin-mediated cell-substratum adhesion in highly-motile and highly-metastatic hepatocellular carcinoma cells."Lab Invest.. 80(3). 387-394 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Takamura,M.,Sakamoto,M.,Genda,T.,Ichida,T.,Asakura,H.,Hirohashi,S.: "Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632."Hepatology. (In press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yamamoto,Y.,Sakamoto,M.,Fujii,G.,Kanetaka,K.,Asaka,M.,Hirohashi,S.: "Cloning and characterization of a nvel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma."Clin.Cancer Res.,. (In press). (2001)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi